Skip to main content
锦好医疗 logo

锦好医疗 — Investor Relations & Filings

Ticker · 920925 Beijing Stock Exchange Manufacturing
Filings indexed 568 across all filing types
Latest filing 2024-10-28 Interim / Quarterly Rep…
Country CN China
Listing Beijing Stock Exchange 920925

About 锦好医疗

https://www.jinghao.cn/

Jinghao Medical specializes in the research, development, and manufacturing of hearing aids and home medical electronic products. The company's core portfolio includes digital and analog hearing aids, medical nebulizers, and electronic blood pressure monitors. It focuses on providing hearing health solutions by integrating advanced digital signal processing technology into its devices. Jinghao Medical operates extensively in the global market, offering original design manufacturing (ODM) and original equipment manufacturing (OEM) services to international partners. The organization emphasizes technological innovation and maintains rigorous quality management systems to comply with international medical device standards. Its primary objective is to deliver accessible, high-performance medical equipment designed to improve the quality of life for users with hearing loss and other chronic health conditions.

Recent filings

Filing Released Lang Actions
2024年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2024 Third Quarter Report" of Huizhou Jin Hao Medical Technology Co., Ltd., with detailed financial data including balance sheets, profit and loss statements, cash flow statements, and explanations of financial changes. It contains comprehensive financial figures for the nine months ending September 30, 2024, and comparisons with prior periods. The document explicitly states it is a quarterly report and includes unaudited financial statements. There is no indication that this is merely an announcement or a certification; the document contains substantive financial data and analysis for a period shorter than a full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2024
2024-10-28 Chinese
第三届监事会第五次会议决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Huizhou Jin Hao Medical Technology Co., Ltd. It details the meeting date, attendance, and voting results on several proposals, including approval of the company's 2024 Q3 report and other financial decisions. The document references the actual 2024 Q3 report being disclosed separately on the Beijing Stock Exchange information platform, indicating this document is not the report itself but a meeting resolution announcement. The document is short (1219 characters) and primarily serves to announce meeting decisions and voting outcomes rather than providing substantive financial data or the report content. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-10-28 Chinese
关于使用部分闲置自有资金购买银行理财产品的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Huizhou Jin Hao Medical Technology Co., Ltd. regarding the use of part of its idle funds to purchase bank financial products. It details the investment purpose, product types, investment amount, duration, implementation method, approval procedures, risk control measures, and impact on the company. The document is a formal announcement about financing activities related to capital management, specifically the use of idle funds for investment in financial products. It is not a full financial report, earnings release, or regulatory filing. It fits best under the category of Capital/Financing Update (CAP) as it updates stakeholders on the company's financing and capital usage activities.
2024-10-28 Chinese
第三届董事会第六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the sixth meeting of the third board of directors of Huizhou Jin Hao Medical Technology Co., Ltd. It details the meeting's attendance, the agenda items discussed, and the voting results on various proposals, including approval of the 2024 Q3 report, use of idle funds, and scheduling of a shareholders meeting. The document does not contain the actual financial report or detailed financial data but references the 2024 Q3 report published elsewhere. It is a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is short (1807 characters), and it is not the report itself but an announcement of board decisions.
2024-10-28 Chinese
中信建投证券股份有限公司关于惠州市锦好医疗科技股份有限公司补充确认调整募投项目募集资金投入金额的专项核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed special verification opinion issued by a sponsoring securities company regarding the adjustment and confirmation of the use of raised funds by a listed company. It includes detailed financial figures about the fundraising, allocation, usage, and adjustments of the raised capital for specific projects. The document references regulatory approvals, fundraising amounts, project investment plans, and internal board approvals. It is not a full annual or interim report, nor an earnings release or call transcript. It is a specialized report related to the use and management of capital raised through public issuance, focusing on the adjustment of investment amounts in fundraising projects. This fits the category of Capital/Financing Update (CAP), as it provides updates on fundraising and capital usage. The document length and detail confirm it is not a mere announcement or certification but a substantive report on capital usage adjustments.
2024-10-28 Chinese
关于召开2024年第二次临时股东大会通知公告(提供网络投票)
AGM Information Classification · 95% confidence The document is a notice announcing the convening of the 2024 second extraordinary general meeting of shareholders (临时股东大会通知公告). It details the meeting date, voting methods, eligibility, agenda items, and registration procedures. There is no financial data, report content, or results disclosed. The document is an announcement about a shareholders meeting, not a report or results announcement. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during or about the Annual General Meeting or other shareholder meetings.
2024-10-28 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.